Home › Gastrointestinal Cancers › Missouri › St. Louis
Gastrointestinal Cancers clinical trials in St. Louis, MO
6 studies for Gastrointestinal Cancers are looking for participants at sites in and around St. Louis (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study of IDRX-42 (GSK6042981) Versus (vs) Sunitinib in Participants With Gastrointestinal Stromal Tumors After Imatinib Therapy
RecruitingPhase 3
- GSK Investigational Site, St Louis
Surgical Thromboprophylaxis Practices in Oncology Patients Within the NCORP Network, STOP-VTE Study
RecruitingObservational studyHealthy volunteers welcome
- Mercy Hospital South, St Louis
- Mercy Hospital Saint Louis, St Louis
Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays
RecruitingHealthy volunteers welcome
- Mercy Infusion Center - Chippewa, St Louis
- Mercy Hospital South, St Louis
- Missouri Baptist Medical Center, St Louis
- and 4 more
A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
RecruitingPhase 1/2
- Washington University Infusion Center Pharmacy, St Louis
A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
RecruitingPhase 1/2
- Washington University School of Medicine, St Louis
Circulating Tumor DNA (ctDNA) for Early Treatment Response Assessment of Solid Tumors
RecruitingObservational studyHealthy volunteers welcome
- Washington University School of Medicine, St Louis
Gastrointestinal Cancers trials in other cities
- Houston, TX21 studies
- Boston, MA15 studies
- New York City, NY12 studies
- Nashville, TN10 studies
- Los Angeles, CA9 studies
- Dallas, TX8 studies
- Cincinnati, OH8 studies
- Durham, NC8 studies
- Baltimore, MD8 studies
- Arlington, VA8 studies
- Baldwin Park, CA7 studies
- Seattle, WA7 studies
Other studies in St. Louis
- Non-Small Cell Lung Cancer73 studies
- Breast Cancer64 studies
- Metastatic Cancer54 studies
- Colorectal Cancer50 studies
- Cancer (all types)46 studies
- Prostate Cancer46 studies
- Lung Cancer39 studies
- Ovarian Cancer38 studies
- Pancreatic Cancer33 studies
- Endometrial Cancer29 studies
- Head and Neck Squamous Cell Carcinoma28 studies
- Heart Failure26 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.